[1]李含阳,张 玉,于 莹.非布司他片治疗痛风伴高尿酸血症的临床研究及其对炎性因子IL-1β和NALP3水平的影响[J].医学信息,2023,36(10):124-127.[doi:10.3969/j.issn.1006-1959.2023.10.027]
　LI Han-yang,ZHANG Yu,YU Ying.Clinical Study of Febuxostat Tablets in the Treatment of Gout with Hyperuricemia and its Effect on the Levels of Inflammatory Factors IL-1β and NALP3[J].Journal of Medical Information,2023,36(10):124-127.[doi:10.3969/j.issn.1006-1959.2023.10.027]
点击复制

非布司他片治疗痛风伴高尿酸血症的临床研究及其对炎性因子IL-1β和NALP3水平的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年10期
页码:
124-127
栏目:
论著
出版日期:
2023-05-15

文章信息/Info

Title:
Clinical Study of Febuxostat Tablets in the Treatment of Gout with Hyperuricemia and its Effect on the Levels of Inflammatory Factors IL-1β and NALP3
文章编号:
1006-1959（2023）10-0124-04
作者:
李含阳; 张 玉; 于 莹
（佳木斯市中心医院药剂科，黑龙江 佳木斯 154002）
Author(s):
LI Han-yang; ZHANG Yu; YU Ying
(Department of Pharmacy,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China)
关键词:
痛风; 高尿酸血症; 非布司他片; 别嘌呤醇片; 血尿酸
Keywords:
Gout; Hyperuricemia; Febuxostat tablets; Allopurinol tablets; Serum uric acid
分类号:
R589.7
DOI:
10.3969/j.issn.1006-1959.2023.10.027
文献标志码:
A
摘要:
目的 研究非布司他片治疗痛风伴高尿酸血症（HUA）的临床疗效，及其对白细胞介素-1β（IL-1β）和嗜中性白细胞碱性磷酸酶家族3（NALP3）水平的影响。方法 纳入2019年12月-2021年10月佳木斯市中心医院收治的60例痛风伴HUA病例，依据随机数字表法分为对照组（30例）和观察组（30例）。对照组给予别嘌呤醇片治疗，观察组应用非布司他片治疗，比较两组临床疗效、血尿酸、血肌酐、炎性因子（IL-1β、NALP3）、不良反应、血尿酸复常率及痛风发作情况。结果 观察组治疗有效率高于对照组（P＜0.05）；两组治疗后血尿酸、血肌酐水平低于治疗前，且观察组血尿酸、血肌酐水平低于对照组（P＜0.05）；观察组治疗后IL-1β、NALP3水平低于对照组（P＜0.05）；两组不良反应发生率比较，差异无统计学意义（P＞0.05）；观察组治疗后血尿酸复常率高于对照组，痛风发作率低于对照组（P＜0.05）。结论 非布司他片治疗痛风伴HUA疗效确切，可降低患者血尿酸、肌酐、IL-1β及NALP3水平，下调炎性反应趋势，改善其血尿酸复常率及痛风发作情况，安全性佳。
Abstract:
Objective To study the clinical efficacy of febuxostat tablets in the treatment of gout with hyperuricemia (HUA) and its effect on the levels of interleukin-1β (IL-1β) and neutrophil alkaline phosphatase family 3 (NALP3).Methods Sixty patients with gout and HUA admitted to Jiamusi Central Hospital from December 2019 to October 2021 were included and divided into control group (30 patients) and observation group (30 patients) according to the random number table method. The control group was treated with allopurinol tablets, and the observation group was treated with febuxostat tablets. The clinical efficacy, blood uric acid, serum creatinine, inflammatory factors (IL-1β, NALP3), adverse reactions, blood uric acid normalization rate and gout attack were compared between the two groups.Results The effective rate of treatment in the observation group was higher than that in the control group (P<0.05). After treatment, the levels of serum uric acid and serum creatinine in the two groups were lower than those before treatment, and the levels of serum uric acid and serum creatinine in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of IL-1β and NALP3 in the observation group were lower than those in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P＞0.05). The recovery rate of serum uric acid in the observation group was higher than that in the control group after treatment, and the attack rate of gout was lower than that in the control group (P<0.05).Conclusion Febuxostat tablets are effective in the treatment of gout with HUA, which can reduce the levels of serum uric acid, creatinine, IL-1β and NALP3, down-regulate the trend of inflammatory response, improve the recovery rate of serum uric acid and gout attack, with good safety.

参考文献/References:

[1]陆飞妃,安首臣,侯冠昕,等.非布司他与别嘌醇对高龄伴心血管疾病高尿酸血症患者有效性及安全性影响[J].临床军医杂志,2021,49(11):1197-1200,1204.[2]全璟平,陈峰.非布司他治疗痛风伴高尿酸血症的有效性及安全性评价[J].山西医药杂志,2021,50(5):722-724.[3]池向耿,蔡琪,王天,等.不同剂量非布司他联合枸橼酸钾缓释片对痛风伴高尿酸血症肾结石患者微炎状态、血管内皮细胞功能的影响[J].陕西医学杂志,2020,49(12):1665-1668.[4]刘岩,李斯琪,刘兵,等.非布司他与别嘌醇治疗高龄高尿酸血症患者的效果和安全性[J].中国临床保健杂志,2020,23(5):607-612.[5]车源霞,晏晨.不同剂量非布司他对痛风伴高尿酸血症患者血清ET-1、血尿酸、MPO及NO水平的影响[J].中国老年学杂志,2020,40(17):3621-3623.[6]中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.痛风及高尿酸血症基层诊疗指南(2019年)[J].中华全科医师杂志,2020,19(4):293-303.[7]郭洪佩,范俊,路臻豪,等.非布司他治疗老年高尿酸血症痛风患者的临床疗效及安全性分析[J].现代生物医学进展,2019,19(19):3780-3783.[8]Shiozawa A,Szabo SM,Bolzani A,et al.Serum Uric Acid and the Risk of Incident and Recurrent Gout: A Systematic Review[J].The Journal of Rheumatology,2017,44(3):388-396.[9]孙昌友,柳青,李清,等.痛风伴高尿酸血症应用非布司他治疗效果及其对QOL评分的影响[J].武警医学,2018,29(11):1021-1023.[10]赵艳红.非布司他和别嘌呤醇治疗原发性痛风疗效和安全性的比较[J].浙江医学,2018,40(10):1088-1090.[11]郭丽环,苏伟海,勾威,等.非布司他与别嘌醇治疗痛风高尿酸血症临床观察[J].中国煤炭工业医学杂志,2018,21(2):158-162.[12]黄新忠,薛海燕,袁莉.非布司他对慢性肾脏病3~5期合并高尿酸血症患者的肾脏保护作用及相关机制[J].中国现代医学杂志,2017,27(26):97-101.[13]朱峰.不同剂量非布司他治疗痛风伴高尿酸血症及肾功能不全患者疗效及安全性观察[J].浙江医学,2017,39(21):1927-1929.[14]孟娟,袁晓旭,路跃武.非布司他与别嘌呤醇治疗原发性痛风的疗效及其对胰岛素抵抗的影响研究[J].中国全科医学,2017,20(30):3745-3748.[15]陈士芳,许瑜佳,殷丽娟,等.非布司他治疗高尿酸血症、高脂血症患者血管内皮功能损伤的临床研究[J].中华内分泌外科杂志,2017,11(5):409-413.[16]黄金沐,池慧琼,林少凯.比较非布司他片与别嘌呤醇片治疗高尿酸血症伴痛风的临床研究[J].中国临床药理学杂志,2017,33(20):2009-2012.[17]Dalbeth N,Phipps-Green A,Frampton C,et al.Relationship between serum urate concentration and clinically evident incident gout: An individual participant data analysis[J].Annals of the Rheumatic Diseases,2018,77(7):1048-1052.[18]张涛,王芳,张文涛,等.非布司他治疗痛风伴高尿酸血症患者的效果及其对血尿酸、TNF-α和sICAM-1水平的影响[J].广西医科大学学报,2017,34(8):1224-1226.[19]Goldberg EL,Asher JL,Molony RD,et al.β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares[J].Cell Reports,2017,18(9):2077-2087.[20]舒涛,蒋中才,高代丽.不同剂量非布司他对痛风伴高尿酸血症患者血尿酸水平及血清ET-1、NO和MPO的影响[J].解放军医药杂志,2017,29(4):106-108,112.[21]李威.非布司他与别嘌醇在痛风中应用的短期临床效果对照分析[J].空军医学杂志,2017,33(1):48-51.[22]White WB,Saag KG,Becker MA,et al.Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout[J].New England Journal of Medicine,2018,378(13):1200-1210.

相似文献/References:

[1]孙 秋,万 明,冯会芳,等.高尿酸血症生化血常规特征分析[J].医学信息,2018,31(06):153.[doi:10.3969/j.issn.1006-1959.2018.06.054]
　SUN Qiu,WAN Ming,FENG Hui-fang,et al.Analysis of Biochemical Blood Routine Characteristics of Hyperuricemia[J].Journal of Medical Information,2018,31(10):153.[doi:10.3969/j.issn.1006-1959.2018.06.054]
[2]俞 瑞,吴建荣,杨晓萍,等.健康体检者中高尿酸人群血脂水平变化及 甘油三脂升高的相关因素分析[J].医学信息,2018,31(13):62.[doi:10.3969/j.issn.1006-1959.2018.13.018]
　YU Rui,WU Jian-rong,YANG Xiao-ping,et al.Analysis of Related Factors of Blood Lipid Levels and Elevated Triglycerides in Hyperuricemia Population in Healthy Subjects[J].Journal of Medical Information,2018,31(10):62.[doi:10.3969/j.issn.1006-1959.2018.13.018]
[3]张 铭,徐 蔷,肖 帆,等.芹菜籽提取物对高尿酸血症模型大鼠的血尿酸以及 抗氧化能力的影响[J].医学信息,2018,31(13):84.[doi:10.3969/j.issn.1006-1959.2018.13.024]
　ZHANG Ming,XU Qiang,XIAO Fan,et al.Effects of Celery Seed Extract on Serum Uric Acid and Antioxidant Capacity of Hyperuricemia Rats[J].Journal of Medical Information,2018,31(10):84.[doi:10.3969/j.issn.1006-1959.2018.13.024]
[4]杨 红,顾小红.体检人群尿酸与脂肪肝的相关性研究[J].医学信息,2018,31(18):57.[doi:10.3969/j.issn.1006-1959.2018.18.018]
　YANG Hong,GU Xiao-hong.Correlation between Uric Acid and Fatty Liver in Physical Examination Population[J].Journal of Medical Information,2018,31(10):57.[doi:10.3969/j.issn.1006-1959.2018.18.018]
[5]何志钧,梁运啸,梁列新.质子泵抑制剂治疗上消化道出血对痛风复发的影响[J].医学信息,2019,32(01):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
　HE Zhi-jun,LIANG Yun-xiao,LIANG Lie-xin.Effect of Proton Pump Inhibitor on Upper Gastrointestinal Hemorrhage on Recurrence of Gout[J].Journal of Medical Information,2019,32(10):154.[doi:10.3969/j.issn.1006-1959.2019.01.048]
[6]朱树花.高尿酸血症与中青年无症状性脑梗死的相关性分析[J].医学信息,2019,32(04):107.[doi:10.3969/j.issn.1006-1959.2019.04.034]
　ZHU Shu-hua.Correlation between Hyperuricemia and Asymptomatic Cerebral Infarction in Young and Middle-aged[J].Journal of Medical Information,2019,32(10):107.[doi:10.3969/j.issn.1006-1959.2019.04.034]
[7]承良凤.芜湖地区痛风急性发作诱因及临床生化特征初探[J].医学信息,2019,32(10):85.[doi:10.3969/j.issn.1006-1959.2019.10.028]
　CHENG Liang-feng.Preliminary Study on the Causes and Clinical Biochemical Characteristics of Acute Gout in Wuhu Area[J].Journal of Medical Information,2019,32(10):85.[doi:10.3969/j.issn.1006-1959.2019.10.028]
[8]查旭雯,夏光云.痛风患者血尿酸和炎性因子水平变化及相关性分析[J].医学信息,2019,32(15):170.[doi:10.3969/j.issn.1006-1959.2019.15.058]
　ZHA Xu-wen,XIA Guang-yun.Changes and Correlation Analysis of Serum Uric Acid and Inflammatory Factors in Patients with Gout[J].Journal of Medical Information,2019,32(10):170.[doi:10.3969/j.issn.1006-1959.2019.15.058]
[9]王云轩,冯 妍,朱平辉,等.社区医务人员高尿酸血症与生活方式的相关性[J].医学信息,2019,32(19):114.[doi:10.3969/j.issn.1006-1959.2019.19.036]
　WANG Yun-xuan,FENG Yan,ZHU Ping-hui,et al.Correlation Between Hyperuricemia and Lifestyle in Community Medical Staff[J].Journal of Medical Information,2019,32(10):114.[doi:10.3969/j.issn.1006-1959.2019.19.036]
[10]胡端凤,罗正辉,李清芳.尿毒清颗粒联合非布司他片治疗高血压肾病合并高尿酸血症的临床研究[J].医学信息,2021,34(23):62.[doi:10.3969/j.issn.1006-1959.2021.23.017]
　HU Duan-feng,LUO Zheng-hui,LI Qing-fang.Clinical Study on Niaoduqing Granules Combined with Febuxostat Tablets in Treatment of Hypertensive Nephropathy Complicated with Hyperuricemia[J].Journal of Medical Information,2021,34(10):62.[doi:10.3969/j.issn.1006-1959.2021.23.017]
[11]李凤敏,顾玲玲,付建茹.非布司他与别嘌醇治疗高尿酸血症伴痛风的疗效比较[J].医学信息,2022,35(01):165.[doi:10.3969/j.issn.1006-1959.2022.01.041]
　LI Feng-min,GU Ling-ling,FU Jian-ru.Comparison of Febuxostat and Allopurinol in the Treatment of Hyperuricemia with Gout[J].Journal of Medical Information,2022,35(10):165.[doi:10.3969/j.issn.1006-1959.2022.01.041]

更新日期/Last Update: 1900-01-01